NASDAQ:LUNG | Free Cash Flow | Pulmonx Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$10.1M$9,000.00-$10.11M
2025-12-31-$7.08M$13,000.00-$7.1M
2025-03-31-$13.22M$301,000.00-$13.52M
2024-12-31-$6.73M$111,000.00-$6.84M
2024-03-31-$11.8M$451,000.00-$12.25M
2023-12-31-$8.45M$200,000.00-$8.65M
2023-03-31-$12.64M$61,000.00-$12.71M
2022-12-31-$9.81M$176,000.00-$9.98M
2022-03-31-$15.03M$564,000.00-$15.59M
2021-12-31-$10.71M$1.15M-$11.86M
2021-03-31-$9.67M$242,000.00-$9.91M
2020-12-31-$7.26M$693,000.00-$7.96M
2020-03-31-$9.85M$81,000.00-$9.93M
2019-12-31-$3.47M$221,000.00-$3.69M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$32.38M$452,000.00-$32.83M
2024-12-31-$31.54M$1.45M-$32.98M
2023-12-31-$37.61M$807,000.00-$38.42M
2022-12-31-$45.08M$1.32M-$46.4M
2021-12-31-$41.39M$3.67M-$45.06M
2020-12-31-$30.63M$911,000.00-$31.54M
2019-12-31-$20.77M$720,000.00-$21.49M
2018-12-31-$18.39M$316,000.00-$18.71M